Literature DB >> 34231134

Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.

Jenny M Norlin1, Klas Kellerborg2, Per Odin3,4,5.   

Abstract

BACKGROUND: Cost-effectiveness models in Parkinson's disease often include health states based on Hoehn and Yahr (H&Y) and time in 'off'. Few studies have investigated utilities in these health states.
OBJECTIVE: The aim of this study was firstly to explore utilities in health states based on H&Y and off-time, and secondly to investigate to what extent H&Y and off-time correlated with EQ-5D dimensions.
METHODS: Patients with idiopathic Parkinson's disease in the National Parkinson's Disease Patient Registry (PARKreg) in Sweden with observations of EQ-5D-3L, H&Y and off-time were included. Correlations with EQ-5D dimensions were analyzed. The relationship between the EQ-5D-3L and H&Y and off-time were estimated by a linear mixed-model with random intercept.
RESULTS: Among patients in PARKreg, 1823 observations fulfilled inclusion criteria. The dimensions 'self-care', 'mobility' and 'usual activities' correlated moderately with H&Y (rs = 0.45, rs = 0.46, rs = 0.45). Weak correlations were found for 'anxiety/depression' and 'pain/discomfort' (rs = 0.24, rs = 0.22) (p values < 0.001). All dimensions correlated weakly with off-time. The fitted model included H&Y, time in 'off', and sex. All H&Y stages were found to be significant and had large and monotonous impact on EQ-5D. Off-time was not significant, but improved the model goodness of fit. Predicted values ranged from 0.733 to - 0.106.
CONCLUSION: This study provides utilities for health states reflecting the current modeling practice of interventions targeting motor symptoms in Parkinson's disease. Future research should investigate patient utilities in health states that also capture non-motor symptoms of the disease, as the management of and options for treatments targeting these symptoms increases.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34231134     DOI: 10.1007/s40273-021-01056-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  38 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Nonmotor symptoms and health-related quality of life in early Parkinson's disease.

Authors:  Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

3.  The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Monica M Kurtis; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

Review 4.  Quality of Life and Nonmotor Symptoms in Parkinson's Disease.

Authors:  Paolo Barone; Roberto Erro; Marina Picillo
Journal:  Int Rev Neurobiol       Date:  2017-07-15       Impact factor: 3.230

5.  Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.

Authors:  Marlene C Hechtner; Thomas Vogt; York Zöllner; Sabrina Schröder; Julia B Sauer; Harald Binder; Susanne Singer; Rafael Mikolajczyk
Journal:  Parkinsonism Relat Disord       Date:  2014-06-10       Impact factor: 4.891

6.  How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  Mov Disord       Date:  2000-11       Impact factor: 10.338

7.  The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

Authors:  C Jenkinson; R Fitzpatrick; V Peto; R Greenhall; N Hyman
Journal:  Age Ageing       Date:  1997-09       Impact factor: 10.668

8.  The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system.

Authors:  K Ray Chaudhuri; A Sauerbier; J M Rojo; K Sethi; A H V Schapira; R G Brown; A Antonini; F Stocchi; P Odin; K Bhattacharya; Y Tsuboi; K Abe; A Rizos; Carmen Rodriguez-Blazquez; P Martinez-Martin
Journal:  Parkinsonism Relat Disord       Date:  2015-01-05       Impact factor: 4.891

9.  Economic burden and quality of life impairment increase with severity of PD.

Authors:  T Keränen; S Kaakkola; K Sotaniemi; V Laulumaa; T Haapaniemi; T Jolma; H Kola; A Ylikoski; O Satomaa; J Kovanen; E Taimela; H Haapaniemi; H Turunen; A Takala
Journal:  Parkinsonism Relat Disord       Date:  2003-01       Impact factor: 4.891

Review 10.  Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

Authors:  Klaus Seppi; K Ray Chaudhuri; Miguel Coelho; Susan H Fox; Regina Katzenschlager; Santiago Perez Lloret; Daniel Weintraub; Cristina Sampaio
Journal:  Mov Disord       Date:  2019-01-17       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.